Literature DB >> 2967691

Effect of propranolol upon protein and proteolytic synthesis activity in hypertrophic myocardium.

B Kwiatkowska-Patzer1, T Zalewska.   

Abstract

The aim of the study was to investigate the effect of propranolol upon protein synthesis and degradation processes in cell-free subfractions of rat myocardium in experimental cardiac hypertrophy induced by aortic stenosis. It was found that hypertrophy stimulates incorporation of 3H-amino acids by the postmitochondrial supernatant (PMS) by 17 +/- 4% (mean +/- SE). Propranolol 10 6M inhibited protein synthesis in the control and experimental groups by 37 +/- 5% and 34 +/- 7%, respectively. At a concentration of 5 X 10 6M, propranolol-induced inhibition in each group was 74 +/- 4% and 58 +/- 5%, respectively. The activity of neutral proteases in PMS of hypertrophic hearts increased up to 255 +/- 29 IU in comparison to 154 +/- 10 IU in controls; in the cytosol it was unchanged. Propranolol had no effect upon the activity of proteases in both fractions. Activity of calcium-activated neutral proteases (CANP) remained at the same level in control and hypertrophic hearts and was unaffected by propranolol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967691     DOI: 10.1007/bf01907103

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  11 in total

1.  Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.

Authors:  R H Swanton; I A Brooksby; B S Jenkins; M M Webb-Peploe
Journal:  Eur J Cardiol       Date:  1977-06

2.  Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.

Authors:  P J Hubner; G M Ziady; G K Lane; T Hardarson; B Scales; C M Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1973-11

3.  A calcium-activated protease possibly involved in myofibrillar protein turnover. Isolation of a low-calcium-requiring form of the protease.

Authors:  W R Dayton; J V Schollmeyer; R A Lepley; L R Cortés
Journal:  Biochim Biophys Acta       Date:  1981-05-14

4.  Calcium-dependent proteolysis in neural tissue is activated at physiologic intracellular Ca2+ levels and inhibited by some anticonvulsants.

Authors:  T M Nosek; M B Crosland
Journal:  J Neurobiol       Date:  1983-01

5.  ATP-dependent proteolysis in erythroid and muscle cells.

Authors:  J D Etlinger; S Speiser; E Wajnberg; M J Glucksman
Journal:  Acta Biol Med Ger       Date:  1981

6.  Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study.

Authors:  C Bourmayan; A Razavi; C Fournier; J C Dussaule; J Baragan; A Gerbaux; J Gay
Journal:  Am Heart J       Date:  1985-06       Impact factor: 4.749

7.  Cardioselective beta blockade in hypertrophic cardiomyopathy.

Authors:  M M Webb-Peplos; R S Croxson; P Khanna; M J Raphael; R E Steiner; C M Oakley; J F Goodwin
Journal:  Acta Cardiol       Date:  1972       Impact factor: 1.718

8.  Role of protein degradation in the growth of livers after a nutritional shift.

Authors:  R D Conde; O A Scornik
Journal:  Biochem J       Date:  1976-08-15       Impact factor: 3.857

9.  Synthesis and degradation of mitochondrial components in hypertrophied rat heart.

Authors:  R Albin; R T Dowell; R Zak; M Rabinowitz
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

10.  Stringent requirement for Ca2+ in the removal of Z-lines and alpha-actinin from isolated myofibrils by Ca2+-activated neutral proteinase.

Authors:  M K Reddy; M Rabinowitz; R Zak
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

View more
  2 in total

1.  Effect of propranolol on the activity of neutral, alkaline and acidic proteases in rat myocardium after aortic stenosis.

Authors:  B Kwiatkowska-Patzer; T Zalewska
Journal:  Basic Res Cardiol       Date:  1987 Jan-Feb       Impact factor: 17.165

2.  Increase in stable isotope ratios driven by metabolic alterations in amphipods exposed to the beta-blocker propranolol.

Authors:  Caroline Ek; Andrius Garbaras; Zhenyang Yu; Hanna Oskarsson; Ann-Kristin Eriksson Wiklund; Linda Kumblad; Elena Gorokhova
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.